NCT00271479View on ClinicalTrials.gov

Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

November 30, 2006

Conditions
Infections, MeningococcalMeningitis, Meningococcic
Interventions
BIOLOGICAL

A, C, Y, W135 meningococcal polysaccharide vaccine

Trial Locations (2)

Unknown

Norwegian Institute of Public Health, Oslo

Mbarara Epicentre Research Base, Mbarara

Sponsors

Lead Sponsor

Epicentre
All Listed Sponsors
collaborator

Norwegian Institute of Public Health

OTHER_GOV

collaborator

University of Oslo

OTHER

collaborator

Medecins Sans Frontieres, Netherlands

OTHER

lead

Epicentre

OTHER

NCT00271479 - Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine | Biotech Hunter | Biotech Hunter